(Elezanumab)Biosimilar Reference Antibody-GS40213

货号：GS40213

Elezanumab (development code ABT-555) is an investigational, fully human monoclonal antibody designed to promote neurological repair and recovery. Unlike most neurological therapies that target symptoms or inflammation, elezanumab functions as a selective neurorestorative agent. Its mechanism is based on modulating a key growth factor pathway to enhance the brain and spinal cord's intrinsic ability to repair itself after injury or damage, thereby aiming to improve functional outcomes such as motor control and sensation.